Similar organisations to TYPE 1 DIABETES INTERNATIONAL
-
Hospitals and Primary Medical Care Facilities
-
1828.
Amani Global Works
Amani Global Works' mission is to provide sustainable healthcare to forgotten areas using #IDJWIISLAND as a model https://t.
1591
New York
-
Cancer
-
1829.
Addario Lung Cancer Medical Institute
We fund and support investigator-led #lungcancer clinical trials.
32
San Carlos
-
AIDS
-
1830.
Sisterhood Mobilized for AIDS-HIV Resources and Treatment
We serve women & youth affected by HIV using food as treatment.
742
New York City
-
Heart and Circulatory
-
1831.
Hypertrophic Cardiomyopaphy Research Foundation Inc
Better health starts with a better health system.
90141
Rye
-
Eye Diseases, Blindness & Vision Impairment
-
1832.
Rand Eye Foundation Inc
The Rand Eye Foundation is committed to education and research in the prevention of blindness.
Pompano Beach
-
Birth Defects, Genetic Diseases
-
1833.
Shwachman-Diamond Syndrome Alliance Inc
Shwachman-Diamond Syndrome Alliance is a nonprofit aimed at accelerating research and therapy development for this rare disease.
954
Woburn
-
Private Grantmaking Foundations
-
1834.
McKesson Foundation
We're an impact-driven healthcare organization dedicated to “Advancing Health Outcomes For All.
48886
Dallas
-
Biological, Life Science Research (includes Marine Biology, Physiology, Biochemistry, Genetics, Biotechnology, etc.)
-
1835.
Oregon Institute of Science and Medicine
RESEARCH, DEVELOPMENT & PUBLIC EDUCATION ON THE BIOCHEMISTRY OF MOLECULAR CLOCKS AND THE DEGENERATIVE DISEASES OF AGING, ELEMENTARY SCIENCE EDUCATION, THE EFFECTS OF ENVIRONMENT ON HEALTH AND WELFARE, AND DISASTER PREPAREDNESS.
Cave Junction
-
Nerve, Muscle, and Bone Diseases
-
1836.
Northeast ALS Consortium Inc
The Northeast ALS Consortium (NEALS) is an international, independent, non-profit group of researchers who collaboratively conduct clinical research in ALS Our mission is to translate scientific advances into clinical research and new treatments for people with Amyotrophic Lateral Sclerosis (ALS) and Motor Neuron Disease (MND) as rapidly as possible, in partnership with the diverse population of people living with ALS, and all those engaged in ALS research.
3219
Boston